{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "23", "@timestamp": "2021-02-23T07:04:29.000029-05:00", "@year": "2021", "@month": "02"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "07"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Ratchadapiseksompotch Fund"}, {"xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University", "xocs:funding-agency-acronym": "MDCU", "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University", "xocs:funding-id": "RA 57/072", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}], "xocs:funding-addon-generated-timestamp": "2021-06-29T22:16:12.270487Z", "xocs:funding-text": "This study was funded by Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, grant number RA 57/072. The funding body had no influence on the design, analysis, or results reported of this study.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "address-part": "1873 Rama IV Road", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Pathumwan", "organization": [{"$": "Division of Rheumatology"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113019942"}, "state": "Bangkok", "@dptid": "113019942"}, "author": [{"ce:given-name": "Manathip", "preferred-name": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Osiri", "@auid": "6701738522", "ce:indexed-name": "Osiri M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60002620", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Center of Excellence in Immunology and Immune-mediated Diseases"}, {"$": "Department of Microbiology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": [{"@afid": "60002620", "@dptid": "103183424"}, {"@afid": "60028190"}], "@dptid": "103183424"}, "author": [{"ce:given-name": "Jongkonnee", "preferred-name": {"ce:given-name": "Jongkonnee", "ce:initials": "J.", "ce:surname": "Wongpiyabovorn", "ce:indexed-name": "Wongpiyabovorn J."}, "@seq": "2", "ce:initials": "J.", "@_fa": "true", "@type": "auth", "ce:surname": "Wongpiyabovorn", "@auid": "15057311000", "ce:indexed-name": "Wongpiyabovorn J."}]}, {"affiliation": {"country": "Thailand", "@afid": "60012718", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Public Health Administration"}, {"$": "Faculty of Public Health"}, {"$": "Mahidol University"}], "affiliation-id": {"@afid": "60012718", "@dptid": "103674656"}, "@dptid": "103674656"}, "author": [{"ce:given-name": "Youwanuch", "preferred-name": {"ce:given-name": "Youwanuch", "ce:initials": "Y.", "ce:surname": "Sattayasomboon", "ce:indexed-name": "Sattayasomboon Y."}, "@seq": "3", "ce:initials": "Y.", "@_fa": "true", "@type": "auth", "ce:surname": "Sattayasomboon", "@auid": "55774940800", "ce:indexed-name": "Sattayasomboon Y."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Immunology"}, {"$": "Department of Microbiology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "110210256"}, "@dptid": "110210256"}, "author": [{"ce:given-name": "Niramol", "preferred-name": {"ce:given-name": "Niramol", "ce:initials": "N.", "ce:surname": "Thammacharoenrach", "ce:indexed-name": "Thammacharoenrach N."}, "@seq": "4", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Thammacharoenrach", "@auid": "6504634079", "ce:indexed-name": "Thammacharoenrach N."}]}], "citation-title": "Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics", "abstracts": "\u00a9 2016, International League of Associations for Rheumatology (ILAR).The objective of this study was to compare the effects of treatment by combined conventional disease-modifying antirheumatic drugs (cDMARDs) or biologics on cytokines, disease activity, and function in rheumatoid arthritis (RA). Sera from a cohort of 81 patients with long-standing RA treated with combined cDMARDs or biologics were measured for 12 cytokines. Comparisons of serum cytokine concentrations with treatment types (combination 2, 3 cDMARDs or biologics), serologic status (positivity for RF and anti-cyclic citrullinated peptide antibody (anti-CCP Ab)), DAS28-ESR, and function were performed. Spearman correlation coefficients between individual cytokines and clinical parameters were explored. Approximately half of the patients were prescribed two cDMARDs. Mean duration of current treatment was 42 months. More than 70 % had moderate disease activity or normal function/slight disability. Serum concentrations of interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17A, IL-23, IL-33, interferon (IFN)-\u03b3, granulocyte monocyte-colony stimulating factor (GM-CSF), and TNF-\u03b1 in patients taking combined cDMARDs did not significantly differ from those on biologics. Seventy-nine serum samples (97.5 %) had undetectable levels of 1 to 10 cytokines. Concentrations of several cytokines were significantly higher in patients with moderate to high disease activity, seropositive or poor functional status. Weak correlations between cytokine levels and RA disease activity or function were demonstrated. The highest correlation coefficients were observed with IL-33, IL-8, and IL-6. Long-term treatment with cDMARDs did not differ from biologics with respect to cytokine concentrations, disease activity, and function. The cytokine profiles in established RA were mainly those produced from effector cells, especially IL-6, IL-8, and IL-33. Both IL-8 and IL-33 may be potential biomarkers and/or treatment targets in patients with late RA.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "1873 Rama IV Road", "postal-code": "10330", "@country": "tha", "city": "Pathumwan", "organization": [{"$": "Division of Rheumatology"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "state": "Bangkok"}, "person": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Biologic agents", "@xml:lang": "eng"}, {"$": "Cytokines", "@xml:lang": "eng"}, {"$": "Disease activity", "@xml:lang": "eng"}, {"$": "Disease-modifying antirheumatic drugs", "@xml:lang": "eng"}, {"$": "Function", "@xml:lang": "eng"}, {"$": "Rheumatoid arthritis", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "link.springer.de/link/service/journals/10067/index.htm", "@type": "email"}}, "translated-sourcetitle": {"$": "Clinical Rheumatology", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "35", "@issue": "7"}, "pagerange": {"@first": "1673", "@last": "1681"}}, "@type": "j", "sourcetitle": "Clinical Rheumatology", "publicationdate": {"month": "07", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 July 2016"}, "day": "01"}, "codencode": "CLRHD", "sourcetitle-abbrev": "Clin. Rheumatol.", "@country": "gbr", "issn": [{"$": "14349949", "@type": "electronic"}, {"$": "07703198", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Springer London"}, "@srcid": "19187"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": [{"classification-code": "86.5.4.3", "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; HUMORAL MEDIATORS OF IMMUNE RESPONSE; Other Factors; Cytokines (general)"}, {"classification-code": "86.8.5.2", "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNE RESPONSE DISORDERS; Autoimmunity; Human studies"}, {"classification-code": "86.8.5.4", "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNE RESPONSE DISORDERS; Autoimmunity; Diagnosis and therapy"}]}, {"@type": "EMCLASS", "classification": [{"classification-code": "26", "classification-description": "Immunology, Serology and Transplantation"}, {"classification-code": "31", "classification-description": "Arthritis and Rheumatism"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": "2745"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "9007-41-4", "chemical-name": "C reactive protein"}, {"cas-registry-number": [{"$": "132-73-0"}, {"$": "3545-67-3"}, {"$": "50-63-5"}, {"$": "54-05-7"}], "chemical-name": "chloroquine"}, {"cas-registry-number": [{"$": "59865-13-3"}, {"$": "63798-73-2"}], "chemical-name": "cyclosporin A"}, {"cas-registry-number": [{"$": "185243-69-0"}, {"$": "200013-86-1"}], "chemical-name": "etanercept"}, {"cas-registry-number": "82115-62-6", "chemical-name": "gamma interferon"}, {"cas-registry-number": [{"$": "118-42-3"}, {"$": "525-31-5"}], "chemical-name": "hydroxychloroquine"}, {"cas-registry-number": "85898-30-2", "chemical-name": "interleukin 2"}, {"cas-registry-number": "114308-91-7", "chemical-name": "interleukin 8"}, {"cas-registry-number": "75706-12-6", "chemical-name": "leflunomide"}, {"cas-registry-number": [{"$": "15475-56-6"}, {"$": "59-05-2"}, {"$": "7413-34-5"}], "chemical-name": "methotrexate"}, {"cas-registry-number": "50-24-8", "chemical-name": "prednisolone"}, {"cas-registry-number": "9009-79-4", "chemical-name": "rheumatoid factor"}, {"cas-registry-number": "599-79-1", "chemical-name": "salazosulfapyridine"}, {"cas-registry-number": "375823-41-9", "chemical-name": "tocilizumab"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Antirheumatic Agents"}, {"chemical-name": "Biological Products"}, {"chemical-name": "Cytokines"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "31", "@timestamp": "BST 16:05:35", "@year": "2017", "@month": "10"}}, "itemidlist": {"itemid": [{"$": "610435203", "@idtype": "PUI"}, {"$": "2016185675", "@idtype": "CABS"}, {"$": "650593128", "@idtype": "CAR-ID"}, {"$": "20160383262", "@idtype": "EMBASE"}, {"$": "27188857", "@idtype": "MEDL"}, {"$": "20161211432", "@idtype": "REAXYSCAR"}, {"$": "2016151630", "@idtype": "RMC"}, {"$": "84969165095", "@idtype": "SCP"}, {"$": "84969165095", "@idtype": "SGR"}, {"$": "614382917", "@idtype": "PUIsecondary"}], "ce:doi": "10.1007/s10067-016-3306-x"}}, "tail": {"bibliography": {"@refcount": "32", "reference": [{"ref-fulltext": "Choy E (2012) Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 5):v3\u2013v11", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "84863861008", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "v3", "@last": "v11"}}, "ref-text": "COI: 1:CAS:528:DC%2BC38XpsVahtbs%3D", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Choy", "ce:indexed-name": "Choy E."}]}, "ref-sourcetitle": "Rheumatology (Oxford)"}}, {"ref-fulltext": "McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Cytokines in the pathogenesis of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "34249720998", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "429", "@last": "442"}}, "ref-text": "COI: 1:CAS:528:DC%2BD2sXls1Kgt74%3D, PID: 17525752", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.B.", "@_fa": "true", "ce:surname": "McInnes", "ce:indexed-name": "McInnes I.B."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Schett", "ce:indexed-name": "Schett G."}]}, "ref-sourcetitle": "Nat Rev Immunol"}}, {"ref-fulltext": "Gizinski AM, Fox DA (2014) T cell subsets and their role in the pathogenesis of rheumatic disease. Curr Opin Rheumatol 26:204\u2013210", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "T cell subsets and their role in the pathogenesis of rheumatic disease"}, "refd-itemidlist": {"itemid": {"$": "84894096187", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26"}, "pagerange": {"@first": "204", "@last": "210"}}, "ref-text": "COI: 1:CAS:528:DC%2BC2cXitFWmtbw%3D, PID: 24445478", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "ce:surname": "Gizinski", "ce:indexed-name": "Gizinski A.M."}, {"@seq": "2", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Fox", "ce:indexed-name": "Fox D.A."}]}, "ref-sourcetitle": "Curr Opin Rheumatol"}}, {"ref-fulltext": "McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. New Engl J Med 365:2205\u20132219", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The pathogenesis of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "84855172814", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "365"}, "pagerange": {"@first": "2205", "@last": "2219"}}, "ref-text": "COI: 1:CAS:528:DC%2BC3MXhs1ajsrrM, PID: 22150039", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.B.", "@_fa": "true", "ce:surname": "McInnes", "ce:indexed-name": "McInnes I.B."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Schett", "ce:indexed-name": "Schett G."}]}, "ref-sourcetitle": "New Engl J Med"}}, {"ref-fulltext": "Davignon JL, Hayder M, Baron M et al (2013) Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 52:590\u2013598", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Targeting monocytes/macrophages in the treatment of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "84875590600", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "590", "@last": "598"}}, "ref-text": "COI: 1:CAS:528:DC%2BC3sXksF2gs74%3D", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Davignon", "ce:indexed-name": "Davignon J.L."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Hayder", "ce:indexed-name": "Hayder M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Baron", "ce:indexed-name": "Baron M."}], "et-al": null}, "ref-sourcetitle": "Rheumatology (Oxford)"}}, {"ref-fulltext": "Furst DE, Emery P (2014) Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford) 53:1560\u20131569", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets"}, "refd-itemidlist": {"itemid": {"$": "84906827120", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "1560", "@last": "1569"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.E.", "@_fa": "true", "ce:surname": "Furst", "ce:indexed-name": "Furst D.E."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Emery", "ce:indexed-name": "Emery P."}]}, "ref-sourcetitle": "Rheumatology (Oxford)"}}, {"ref-fulltext": "Okada Y, Wu D, Trynka G et al (2014) Genetics of rheumatoid arthritis contribute to biology and drug discovery. Nature 506:376\u2013381", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Genetics of rheumatoid arthritis contribute to biology and drug discovery"}, "refd-itemidlist": {"itemid": {"$": "84894288992", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "506"}, "pagerange": {"@first": "376", "@last": "381"}}, "ref-text": "COI: 1:CAS:528:DC%2BC2cXivVCjs78%3D, PID: 24390342", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Okada", "ce:indexed-name": "Okada Y."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Wu", "ce:indexed-name": "Wu D."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Trynka", "ce:indexed-name": "Trynka G."}], "et-al": null}, "ref-sourcetitle": "Nature"}}, {"ref-fulltext": "Alunno A, Manetti M, Caterbi S et al. (2015) Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications. Mediators Inflam 751793", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications"}, "refd-itemidlist": {"itemid": {"$": "84928255177", "@idtype": "SGR"}}, "ref-text": "751793", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Alunno", "ce:indexed-name": "Alunno A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Manetti", "ce:indexed-name": "Manetti M."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Caterbi", "ce:indexed-name": "Caterbi S."}]}, "ref-sourcetitle": "Mediators Inflam"}}, {"ref-fulltext": "Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631\u2013637", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Treating rheumatoid arthritis to target: recommendations of an international task force"}, "refd-itemidlist": {"itemid": {"$": "77950307115", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "69"}, "pagerange": {"@first": "631", "@last": "637"}}, "ref-text": "PID: 20215140", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Smolen", "ce:indexed-name": "Smolen J.S."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Aletaha", "ce:indexed-name": "Aletaha D."}, {"@seq": "3", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Bijlsma", "ce:indexed-name": "Bijlsma J.W."}], "et-al": null}, "ref-sourcetitle": "Ann Rheum Dis"}}, {"ref-fulltext": "Smolen JS, Breedveld FC, Burmester GR et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75:3\u201315", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force"}, "refd-itemidlist": {"itemid": {"$": "84930607509", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "75"}, "pagerange": {"@first": "3", "@last": "15"}}, "ref-text": "PID: 25969430", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Smolen", "ce:indexed-name": "Smolen J.S."}, {"@seq": "2", "ce:initials": "F.C.", "@_fa": "true", "ce:surname": "Breedveld", "ce:indexed-name": "Breedveld F.C."}, {"@seq": "3", "ce:initials": "G.R.", "@_fa": "true", "ce:surname": "Burmester", "ce:indexed-name": "Burmester G.R."}], "et-al": null}, "ref-sourcetitle": "Ann Rheum Dis"}}, {"ref-fulltext": "Mottonen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group Lancet 353:1568\u20131573", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial"}, "refd-itemidlist": {"itemid": {"$": "0033535754", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "353"}, "pagerange": {"@first": "1568", "@last": "1573"}}, "ref-text": "COI: 1:CAS:528:DyaK1MXjsFyjsbw%3D, PID: 10334255", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Mottonen", "ce:indexed-name": "Mottonen T."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Hannonen", "ce:indexed-name": "Hannonen P."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Leirisalo-Repo", "ce:indexed-name": "Leirisalo-Repo M."}], "et-al": null}, "ref-sourcetitle": "FIN-RACo trial group. Lancet"}}, {"ref-fulltext": "Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263\u2013269", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial"}, "refd-itemidlist": {"itemid": {"$": "3242677099", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "364"}, "pagerange": {"@first": "263", "@last": "269"}}, "ref-text": "PID: 15262104", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Grigor", "ce:indexed-name": "Grigor C."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Capell", "ce:indexed-name": "Capell H."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Stirling", "ce:indexed-name": "Stirling A."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52:3381\u20133390", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial"}, "refd-itemidlist": {"itemid": {"$": "27744514865", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "3381", "@last": "3390"}}, "ref-text": "COI: 1:CAS:528:DC%2BD2MXht1KrtbfL, PID: 16258899", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.P.", "@_fa": "true", "ce:surname": "Goekoop-Ruiterman", "ce:indexed-name": "Goekoop-Ruiterman Y.P."}, {"@seq": "2", "ce:initials": "J.K.", "@_fa": "true", "ce:surname": "de Vries-Bouwstra", "ce:indexed-name": "de Vries-Bouwstra J.K."}, {"@seq": "3", "ce:initials": "C.F.", "@_fa": "true", "ce:surname": "Allaart", "ce:indexed-name": "Allaart C.F."}], "et-al": null}, "ref-sourcetitle": "Arthritis Rheum"}}, {"ref-fulltext": "Verstappen SM, Jacobs JW, van der Veen MJ et al (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66:1443\u20131449", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)"}, "refd-itemidlist": {"itemid": {"$": "35648991026", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "66"}, "pagerange": {"@first": "1443", "@last": "1449"}}, "ref-text": "COI: 1:CAS:528:DC%2BD2sXhtlGrt7fE, PID: 17519278", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Verstappen", "ce:indexed-name": "Verstappen S.M."}, {"@seq": "2", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Jacobs", "ce:indexed-name": "Jacobs J.W."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "van der Veen", "ce:indexed-name": "van der Veen M.J."}], "et-al": null}, "ref-sourcetitle": "Ann Rheum Dis"}}, {"ref-fulltext": "Bakker MF, Jacobs JW, Welsing PM et al (2012) Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Intern Med 156:329\u2013339", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial"}, "refd-itemidlist": {"itemid": {"$": "84857697133", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "156"}, "pagerange": {"@first": "329", "@last": "339"}}, "ref-text": "PID: 22393128", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.F.", "@_fa": "true", "ce:surname": "Bakker", "ce:indexed-name": "Bakker M.F."}, {"@seq": "2", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Jacobs", "ce:indexed-name": "Jacobs J.W."}, {"@seq": "3", "ce:initials": "P.M.", "@_fa": "true", "ce:surname": "Welsing", "ce:indexed-name": "Welsing P.M."}], "et-al": null}, "ref-sourcetitle": "Ann Intern Med"}}, {"ref-fulltext": "Hirata S, Dirven L, Shen Y et al (2013) A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Rheumatology (Oxford) 52:1202\u20131207", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study"}, "refd-itemidlist": {"itemid": {"$": "84879835300", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "1202", "@last": "1207"}}, "ref-text": "COI: 1:CAS:528:DC%2BC3sXhtVeiu7fM", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Hirata", "ce:indexed-name": "Hirata S."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Dirven", "ce:indexed-name": "Dirven L."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Shen", "ce:indexed-name": "Shen Y."}], "et-al": null}, "ref-sourcetitle": "Rheumatology (Oxford)"}}, {"ref-fulltext": "Segurado OG, Sasso EH (2014) Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 32(Suppl 85):S29\u2013S34", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "84922395196", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "S29", "@last": "S34"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "O.G.", "@_fa": "true", "ce:surname": "Segurado", "ce:indexed-name": "Segurado O.G."}, {"@seq": "2", "ce:initials": "E.H.", "@_fa": "true", "ce:surname": "Sasso", "ce:indexed-name": "Sasso E.H."}]}, "ref-sourcetitle": "Clin Exp Rheumatol"}}, {"ref-fulltext": "Li W, Sasso EH, Emerling D et al (2013) Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use. Curr Med Res Opin 29:85\u201392", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use"}, "refd-itemidlist": {"itemid": {"$": "84871368232", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "85", "@last": "92"}}, "ref-text": "PID: 23176063", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li W."}, {"@seq": "2", "ce:initials": "E.H.", "@_fa": "true", "ce:surname": "Sasso", "ce:indexed-name": "Sasso E.H."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Emerling", "ce:indexed-name": "Emerling D."}], "et-al": null}, "ref-sourcetitle": "Curr Med Res Opin"}}, {"ref-fulltext": "Wu B, Wilson A, Wang F et al (2012) Cost effectiveness of different treatment strategies in the treatment of patients with moderate to severe rheumatoid arthritis in China. PLoS One. doi:10.1371/journal.pone.0047373", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Cost effectiveness of different treatment strategies in the treatment of patients with moderate to severe rheumatoid arthritis in China"}, "refd-itemidlist": {"itemid": {"$": "84867644293", "@idtype": "SGR"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wu", "ce:indexed-name": "Wu B."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Wilson", "ce:indexed-name": "Wilson A."}, {"@seq": "3", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang F."}], "et-al": null}, "ref-sourcetitle": "PLoS One"}}, {"ref-fulltext": "Fragoulakis V, Vitsou E, Hernandez AC et al (2015) Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece. Clinicoecon Outcomes Res 7:85\u201393", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece"}, "refd-itemidlist": {"itemid": {"$": "84921780190", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "85", "@last": "93"}}, "ref-text": "PID: 25653545", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Fragoulakis", "ce:indexed-name": "Fragoulakis V."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Vitsou", "ce:indexed-name": "Vitsou E."}, {"@seq": "3", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Hernandez", "ce:indexed-name": "Hernandez A.C."}], "et-al": null}, "ref-sourcetitle": "Clinicoecon Outcomes Res"}}, {"ref-fulltext": "Thai Rheumatism Association (2008) Guideline for biological therapy in rheumatoid arthritis. http://www.thairheumatology.org/download/guideline_biolo_gic_therapy.pdf (Thai language) Accessed 1 December 2015", "@id": "21", "ref-info": {"ref-website": {"ce:e-address": {"$": "http://www.thairheumatology.org/download/guideline_biolo_gic_therapy.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84975605534", "@idtype": "SGR"}}, "ref-text": "Thai Rheumatism Association (2008) Guideline for biological therapy in rheumatoid arthritis. (Thai language) Accessed 1 December 2015"}}, {"ref-fulltext": "Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "ref-title": {"ref-titletext": "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "0023945481", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31"}, "pagerange": {"@first": "315", "@last": "324"}}, "ref-text": "COI: 1:STN:280:DyaL1c7pt1Ohsg%3D%3D, PID: 3358796", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.C.", "@_fa": "true", "ce:surname": "Arnett", "ce:indexed-name": "Arnett F.C."}, {"@seq": "2", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Edworthy", "ce:indexed-name": "Edworthy S.M."}, {"@seq": "3", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Bloch", "ce:indexed-name": "Bloch D.A."}], "et-al": null}, "ref-sourcetitle": "Arthritis Rheum"}}, {"ref-fulltext": "Osiri M, Wongchinsri J, Ukritchon S et al (2009) Comprehensibility, reliability, validity and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis. Arthritis Res Ther 11:R129", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Comprehensibility, reliability, validity and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "73349115893", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "R129"}}, "ref-text": "PID: 19709443", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wongchinsri", "ce:indexed-name": "Wongchinsri J."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ukritchon", "ce:indexed-name": "Ukritchon S."}], "et-al": null}, "ref-sourcetitle": "Arthritis Res Ther"}}, {"ref-fulltext": "Bartels EM, Ribel-Madsen S (2013) Cytokine measurements and possible interference from heterophilic antibodies\u2014problems and solutions experienced with rheumatoid factor. Methods 61:18\u201322", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Cytokine measurements and possible interference from heterophilic antibodies\u2014problems and solutions experienced with rheumatoid factor"}, "refd-itemidlist": {"itemid": {"$": "84878864519", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "18", "@last": "22"}}, "ref-text": "PID: 23306035", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.M.", "@_fa": "true", "ce:surname": "Bartels", "ce:indexed-name": "Bartels E.M."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ribel-Madsen", "ce:indexed-name": "Ribel-Madsen S."}]}, "ref-sourcetitle": "Methods"}}, {"ref-fulltext": "Boers M, Verhoeven AC, Markusse HM et al (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350:309\u2013318", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "0030751946", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "350"}, "pagerange": {"@first": "309", "@last": "318"}}, "ref-text": "COI: 1:CAS:528:DyaK2sXls1emtbc%3D, PID: 9251634", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Boers", "ce:indexed-name": "Boers M."}, {"@seq": "2", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Verhoeven", "ce:indexed-name": "Verhoeven A.C."}, {"@seq": "3", "ce:initials": "H.M.", "@_fa": "true", "ce:surname": "Markusse", "ce:indexed-name": "Markusse H.M."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "O\u2019Dell JR, Mikuls TR, Taylor TH et al (2013) Therapies for active rheumatoid arthritis after methotrexate failure. New Engl J Med 369:307\u2013318", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Therapies for active rheumatoid arthritis after methotrexate failure"}, "refd-itemidlist": {"itemid": {"$": "84880753128", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "369"}, "pagerange": {"@first": "307", "@last": "318"}}, "ref-text": "PID: 23755969", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.R.", "@_fa": "true", "ce:surname": "O\u2019Dell", "ce:indexed-name": "O'Dell J.R."}, {"@seq": "2", "ce:initials": "T.R.", "@_fa": "true", "ce:surname": "Mikuls", "ce:indexed-name": "Mikuls T.R."}, {"@seq": "3", "ce:initials": "T.H.", "@_fa": "true", "ce:surname": "Taylor", "ce:indexed-name": "Taylor T.H."}], "et-al": null}, "ref-sourcetitle": "New Engl J Med"}}, {"ref-fulltext": "Scott DL, Ibrahim F, Farewell V et al (2015) Therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial. BMJ 350:h1046", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial"}, "refd-itemidlist": {"itemid": {"$": "84961290062", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "350"}, "pagerange": {"@first": "h1046"}}, "ref-text": "PID: 25769495", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.L.", "@_fa": "true", "ce:surname": "Scott", "ce:indexed-name": "Scott D.L."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Ibrahim", "ce:indexed-name": "Ibrahim F."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Farewell", "ce:indexed-name": "Farewell V."}], "et-al": null}, "ref-sourcetitle": "BMJ"}}, {"ref-fulltext": "Alex P, Szodoray P, Knowlton N et al (2007) Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritis. Clin Exp Rheumatol 25:584\u2013592", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "34748923509", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "25"}, "pagerange": {"@first": "584", "@last": "592"}}, "ref-text": "COI: 1:STN:280:DC%2BD2srmvVKgsg%3D%3D, PID: 17888215", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Alex", "ce:indexed-name": "Alex P."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Szodoray", "ce:indexed-name": "Szodoray P."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Knowlton", "ce:indexed-name": "Knowlton N."}], "et-al": null}, "ref-sourcetitle": "Clin Exp Rheumatol"}}, {"ref-fulltext": "Raza K, Falciani F, Curnow SJ et al (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stronal cell origin. Arthritis Res Ther 7:R784\u2013R795", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stronal cell origin"}, "refd-itemidlist": {"itemid": {"$": "21644479222", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "R784", "@last": "R795"}}, "ref-text": "COI: 1:CAS:528:DC%2BD2MXkt1CjsLk%3D, PID: 15987480", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Raza", "ce:indexed-name": "Raza K."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Falciani", "ce:indexed-name": "Falciani F."}, {"@seq": "3", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Curnow", "ce:indexed-name": "Curnow S.J."}], "et-al": null}, "ref-sourcetitle": "Arthritis Res Ther"}}, {"ref-fulltext": "Hueber W, Tomooka BH, Zhao X et al (2007) Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis 66:712\u2013719", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines"}, "refd-itemidlist": {"itemid": {"$": "34249827580", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "66"}, "pagerange": {"@first": "712", "@last": "719"}}, "ref-text": "COI: 1:CAS:528:DC%2BD2sXntlOnu7g%3D, PID: 16901957", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Hueber", "ce:indexed-name": "Hueber W."}, {"@seq": "2", "ce:initials": "B.H.", "@_fa": "true", "ce:surname": "Tomooka", "ce:indexed-name": "Tomooka B.H."}, {"@seq": "3", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Zhao", "ce:indexed-name": "Zhao X."}], "et-al": null}, "ref-sourcetitle": "Ann Rheum Dis"}}, {"ref-fulltext": "Wright HL, Bucknall RC, Moots RJ et al (2012) Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology (Oxford) 51:451\u2013459", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy"}, "refd-itemidlist": {"itemid": {"$": "84857612440", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "451", "@last": "459"}}, "ref-text": "COI: 1:CAS:528:DC%2BC38Xisl2lsrw%3D", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.L.", "@_fa": "true", "ce:surname": "Wright", "ce:indexed-name": "Wright H.L."}, {"@seq": "2", "ce:initials": "R.C.", "@_fa": "true", "ce:surname": "Bucknall", "ce:indexed-name": "Bucknall R.C."}, {"@seq": "3", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Moots", "ce:indexed-name": "Moots R.J."}], "et-al": null}, "ref-sourcetitle": "Rheumatology (Oxford)"}}, {"ref-fulltext": "McInnes IB, Buckley CD, Isaacs JD (2016) Cytokines in rheumatoid arthritis-shaping the immunological landscape. Nat Rev Rheumatol 12:163\u2013168", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Cytokines in rheumatoid arthritis-shaping the immunological landscape"}, "refd-itemidlist": {"itemid": {"$": "84954197348", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "163", "@last": "168"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.B.", "@_fa": "true", "ce:surname": "McInnes", "ce:indexed-name": "McInnes I.B."}, {"@seq": "2", "ce:initials": "C.D.", "@_fa": "true", "ce:surname": "Buckley", "ce:indexed-name": "Buckley C.D."}, {"@seq": "3", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "Isaacs", "ce:indexed-name": "Isaacs J.D."}]}, "ref-sourcetitle": "Nat Rev Rheumatol"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Nakhon Pathom", "@id": "60012718", "affilname": "Mahidol University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60002620", "affilname": "Faculty of Medicine, Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84969165095", "dc:description": "The objective of this study was to compare the effects of treatment by combined conventional disease-modifying antirheumatic drugs (cDMARDs) or biologics on cytokines, disease activity, and function in rheumatoid arthritis (RA). Sera from a cohort of 81 patients with long-standing RA treated with combined cDMARDs or biologics were measured for 12 cytokines. Comparisons of serum cytokine concentrations with treatment types (combination 2, 3 cDMARDs or biologics), serologic status (positivity for RF and anti-cyclic citrullinated peptide antibody (anti-CCP Ab)), DAS28-ESR, and function were performed. Spearman correlation coefficients between individual cytokines and clinical parameters were explored. Approximately half of the patients were prescribed two cDMARDs. Mean duration of current treatment was 42 months. More than 70 % had moderate disease activity or normal function/slight disability. Serum concentrations of interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17A, IL-23, IL-33, interferon (IFN)-\u03b3, granulocyte monocyte-colony stimulating factor (GM-CSF), and TNF-\u03b1 in patients taking combined cDMARDs did not significantly differ from those on biologics. Seventy-nine serum samples (97.5 %) had undetectable levels of 1 to 10 cytokines. Concentrations of several cytokines were significantly higher in patients with moderate to high disease activity, seropositive or poor functional status. Weak correlations between cytokine levels and RA disease activity or function were demonstrated. The highest correlation coefficients were observed with IL-33, IL-8, and IL-6. Long-term treatment with cDMARDs did not differ from biologics with respect to cytokine concentrations, disease activity, and function. The cytokine profiles in established RA were mainly those produced from effector cells, especially IL-6, IL-8, and IL-33. Both IL-8 and IL-33 may be potential biomarkers and/or treatment targets in patients with late RA.", "pubmed-id": "27188857", "prism:coverDate": "2016-07-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84969165095", "dc:creator": {"author": [{"ce:given-name": "Manathip", "preferred-name": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Osiri", "@auid": "6701738522", "author-url": "https://api.elsevier.com/content/author/author_id/6701738522", "ce:indexed-name": "Osiri M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84969165095"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84969165095&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84969165095&origin=inward"}], "source-id": "19187", "citedby-count": "20", "prism:volume": "35", "subtype": "ar", "dc:title": "Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics", "openaccess": "0", "prism:issn": "14349949 07703198", "publishercopyright": "\u00a9 2016, International League of Associations for Rheumatology (ILAR).", "prism:issueIdentifier": "7", "subtypeDescription": "Article", "prism:publicationName": "Clinical Rheumatology", "prism:pageRange": "1673-1681", "prism:endingPage": "1681", "openaccessFlag": "false", "prism:doi": "10.1007/s10067-016-3306-x", "prism:startingPage": "1673", "dc:identifier": "SCOPUS_ID:84969165095", "dc:publisher": "Springer London"}, "idxterms": {"mainterm": [{"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Aged, 80 and over", "@weight": "b", "@candidate": "n"}, {"$": "Antirheumatic Agents", "@weight": "b", "@candidate": "n"}, {"$": "Arthritis, Rheumatoid", "@weight": "b", "@candidate": "n"}, {"$": "Biological Products", "@weight": "b", "@candidate": "n"}, {"$": "Cytokines", "@weight": "b", "@candidate": "n"}, {"$": "Drug Therapy, Combination", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Severity of Illness Index", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Biologic agents"}, {"@_fa": "true", "$": "Cytokines"}, {"@_fa": "true", "$": "Disease activity"}, {"@_fa": "true", "$": "Disease-modifying antirheumatic drugs"}, {"@_fa": "true", "$": "Function"}, {"@_fa": "true", "$": "Rheumatoid arthritis"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Rheumatology", "@code": "2745", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Manathip", "preferred-name": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Osiri", "@auid": "6701738522", "author-url": "https://api.elsevier.com/content/author/author_id/6701738522", "ce:indexed-name": "Osiri M."}, {"ce:given-name": "Jongkonnee", "preferred-name": {"ce:given-name": "Jongkonnee", "ce:initials": "J.", "ce:surname": "Wongpiyabovorn", "ce:indexed-name": "Wongpiyabovorn J."}, "@seq": "2", "ce:initials": "J.", "@_fa": "true", "affiliation": {"@id": "60002620", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"}, "ce:surname": "Wongpiyabovorn", "@auid": "15057311000", "author-url": "https://api.elsevier.com/content/author/author_id/15057311000", "ce:indexed-name": "Wongpiyabovorn J."}, {"ce:given-name": "Youwanuch", "preferred-name": {"ce:given-name": "Youwanuch", "ce:initials": "Y.", "ce:surname": "Sattayasomboon", "ce:indexed-name": "Sattayasomboon Y."}, "@seq": "3", "ce:initials": "Y.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Sattayasomboon", "@auid": "55774940800", "author-url": "https://api.elsevier.com/content/author/author_id/55774940800", "ce:indexed-name": "Sattayasomboon Y."}, {"ce:given-name": "Niramol", "preferred-name": {"ce:given-name": "Niramol", "ce:initials": "N.", "ce:surname": "Thammacharoenrach", "ce:indexed-name": "Thammacharoenrach N."}, "@seq": "4", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Thammacharoenrach", "@auid": "6504634079", "author-url": "https://api.elsevier.com/content/author/author_id/6504634079", "ce:indexed-name": "Thammacharoenrach N."}]}}}